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Abstract
Transcriptome measurements of individual cells reflect unexplored biological diversity, but are 
also affected by technical noise and bias. This raises the need to model and account for the 
resulting uncertainty in any downstream analysis. Here, we introduce Single-cell Variational 
Inference (scVI), a scalable framework for probabilistic representation and analysis of gene 
expression in single cells. scVI uses stochastic optimization and deep neural networks to aggregate 
information across similar cells and genes and approximate the distributions that underlie the 
observed expression values, while accounting for batch effects and limited sensitivity. We utilize 
scVI for a range of fundamental analysis tasks – including batch correction, visualization, 
clustering and differential expression – and demonstrate its accuracy and scalability in comparison 
to the state-of-the-art in each task. scVI is publicly available and can be readily used as a 
principled and inclusive solution for analyzing single-cell transcriptomes.
Introduction
The ability to map single cell transcriptomes en-mass with single-cell RNA sequencing 
(scRNA-seq) provides a powerful tool, which is beginning to make important contributions 
to diverse research areas such as development [1], autoimmunity [2], and cancer [3]. 
Interpreting scRNA-seq remains challenging, however, as the data is confounded by 
nuisance factors such as limited [4] and variable [5] sensitivity, batch effects [6] and 
transcriptional noise [7].
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The challenge of modeling bias and uncertainty in single-cell data has been explored in 
several recent studies, where a common theme is treating each data point (cell × gene) as a 
random variable for which a probabilistic model is fit [8, 9, 10]. The parameters of these 
models are determined by a combination of cell- and gene-level coefficients (and in some 
cases additional metadata such as library depth [10]), thus providing a representation of the 
data in a lower and potentially less noisy dimension. Once these models have been fit, they 
can then in principle be used for various tasks such as clustering [11], imputation [12] or 
differential expression [13]. A complementary line of studies focuses on only one of these 
tasks, in some cases without explicit probabilistic modeling.
While these methods helped gain new insights into the meaning of biological variation 
between cells, several limitations remain. First, the existing distributional modeling methods 
assume that a low-dimensional manifold underlies the data, and that the mapping into this 
manifold can be captured by a generalized linear model. While the notion of a restricted 
dimensionality is plausible (e.g., reflecting common regulatory mechanisms among genes or 
common states among cells), it is difficult to justify the assumption of linearity. Second, 
different existing methods utilize their models to perform different subsets of tasks (e.g., 
imputation and clustering, but not differential expression [8]). Ideally, one would have a 
single distributional model that can be used for a range of downstream tasks, thus help 
ensuring consistency and interpretability. Finally, computational scalability is increasingly 
important. While most existing methods can be applied to no more than tens of thousands of 
cells, the next generation of tools must scale to the size of recent data sets that consist of 
hundreds of thousands of cells or more [14].
To address these limitations, we developed a fully probabilistic approach for normalization 
and downstream analysis of scRNA-seq data, which we refer to as Single-cell Variational 
Inference (scVI). scVI is based on a hierarchical Bayesian model [15] with conditional 
distributions specified by deep neural networks, which can be trained very efficiently even 
for very large datasets. The transcriptome of each cell is encoded through a non-linear 
transformation into a low-dimensional latent vector of normal random variables. This latent 
representation is then decoded by another non-linear transformation to generate a posterior 
estimate of the distributional parameters of each gene in each cell, assuming a zero-inflated 
negative binomial distribution, which accounts for the observed over-dispersion and limited 
sensitivity [10, 16, 17]. Independent of our work, several recent manuscripts have also 
demonstrated the utility of using neural networks to embed scRNA-seq datasets in a scalable 
manner [18, 19, 20, 21]. scVI stands out from these methods in two important ways (Online 
Methods, Supplementary Note 1, Supplementary Table 1). First, it is the only method that 
explicitly models the two key nuisance factors in scRNA-seq data, namely library size [8, 
22] and batch effects [10, 23]. Second, scVI is the only method that offers readily available 
solutions for a range of analysis tasks using the same generative model. In the following, we 
demonstrate this property, focusing on batch removal and normalization, dimensionality 
reduction and clustering, and differential expression. For each of these tasks, we show that 
scVI compares favorably to the current state-of-the-art methods.
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Results
The scVI model: definition and preliminary evaluation
We model the observed expression xng of each gene g in each cell n as a sample drawn from 
a conditional distribution that has a zero-inflated negative binomial (ZINB) form [10, 16, 17] 
(Online Methods). The distribution is conditioned on the batch annotation bn of each cell (if 
available), as well as two additional, unobserved random variables. The first variable ℓn is a 
one-dimensional Gaussian that represents nuisance variation due to differences in capture 
efficiency and sequencing depth, serving as a cell-specific scaling factor. The second 
variable zn is a low dimensional vector of Gaussians (set here to 10 dimensions; see 
Supplementary Figure 1) representing the remaining variation, which should better reflect 
biological differences between cells [24]. We use it to represent each cell as a point in a low 
dimensional latent space, serving for visualization and clustering. We learn the distribution 
of these latent variables q(zn,logℓn|xn,sn), by training a neural network that approximates 
their posterior using variational inference and a scalable stochastic optimization procedure 
[25, 26, 27] (Figure 1a, NN1–4). The second part of our model consists of another neural 
network that generates a posterior ZINB distribution of the data p(xng|zn,sn,ℓn) from the 
latent variables (Figure 1a, NN5–6). This generative scheme consists of intermediate values 
ρg
n
, which provide a batch-corrected, normalized estimate of the percentage of transcripts in 
each cell n that originate from each gene g. We use the matrix ρ for differential expression 
analysis and its scaled version (multiplying ρgn by the estimated library size ℓn) for 
imputation. In the following sections we evaluate scVI using a collection of published 
datasets, spanning a range of technical and biological characteristics. These datasets are 
listed in Supplementary Table 2 and described in the Online Methods section.
To evaluate the scalability of our training procedure, we use a data set of 1.3 million mouse 
brain cells provided by 10x [28] (BRAIN-LARGE) and record the time required to fit the 
model for increasing numbers of randomly sampled cells. To facilitate comparison to state-
of-the-art algorithms for probabilistic modeling and dimensionality reduction of single cell 
data [8, 9, 10, 11, 12] which may be less scalable, we limited this analysis to the 720 genes 
with largest standard deviation across all cells and report results in Figure 1b. We find that 
most methods are capable of processing up to 50K cells before running out of memory 
(using 32Gb RAM). Conversely, we find that scVI is generally faster and capable of scaling 
to the full range of our tests (1M cells), thanks to its reliance on iterative stochastic 
optimization, where one only uses a fixed number of cells at each iteration (Online 
Methods). We also observe similar levels of scalability with DCA [20] a denoising auto-
encoder, which also uses stochastic optimization. Notably, as the dataset size reaches one 
million cells, fewer training iterations (or epochs) are needed and heuristics for stopping the 
learning process may save time. Indeed, we observe that the standard scVI (which uses a 
fixed number of epochs) is slower than DCA (which uses the stopping heuristic by default) 
in this case, however, turning the early- stopping option on makes scVI substantially faster 
(trained in less than an hour), and fit the data as well a run with no early stopping 
(Supplementary Figure 2).
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Next, we evaluated the extent to which scVI and the benchmark methods fit the data by 
assessing their ability to accurately impute missing data. We used five data sets of different 
sizes (3– 27k cells; see Supplementary Table 2; [28, 29, 30, 31, 32]; BRAIN-LARGE, 
CORTEX, PBMC, RETINA, HEMATO), where in each case we set 9% of the non-zero 
entries (chosen entirely randomly in Supplementary Figures 3 and 4, or preferring low 
values in Supplementary Figures 5 and 6) to zero and then test the ability of each benchmark 
method to recapitulate their values. Overall, we observe that in most cases methods that are 
based on a ZINB distribution, namely scVI, DCA and ZINB-WaVE (when it scales to the 
dataset size) perform better than ones that use alternative strategies [8, 12] (e.g., log normal 
[9] in ZIFA), thus supporting the notion that ZINB is appropriate for current scRNA-seq 
datasets. One important exception where MAGIC [12] (which imputes using propagation in 
a cell-cell similarity graph) outperformed scVI occurred with a dataset of hematopoietic 
differentiation [32] (HEMATO), in which the number of cells (4,016) is smaller than the 
number of genes (7,397). In such cases, scVI is expected to under-fit the data, potentially 
leading to worse imputation accuracy. However, additional gene filtering (to the top 700 
variable genes) helped regaining a more accurate imputation (Supplementary Figure 3c). An 
alternative way to evaluate model fit is by testing the likelihood of data that was held-out 
during training. Using this procedure yields consistent results as above (Supplementary 
Figure 7, Supplementary Table 3). Furthermore, scVI, like ZIFA and FA, can also be used to 
generate unseen data by sampling from the latent space. As evidence of the validity of this 
procedure, we sampled from the posterior distribution given the perturbed training data and 
observed that the samples are largely consistent with the unperturbed data (Supplementary 
Figure 8).
Capturing biological structure in a latent low-dimensional space
We next turned to evaluate the extent to which the latent space inferred by scVI reflects 
biological variability between cells. One way to assess this is to rely on prior stratification of 
the cells into biologically meaningful sub-populations, which is normally done by 
unsupervised clustering followed by manual inspection and annotation [29, 30]. We evaluate 
the accuracy with respect to these stratifications (available in two of our reference data sets 
[29, 30]; CORTEX, PBMC) by either applying k-means clustering on the latent space and 
testing for the overlap with the annotated sub-populations (using the same k as in the 
annotated data), or by comparing between the proximity of cells in the same sub-population 
to the proximity of cells from different sub-populations (Online Methods). A data set 
provided by Stoeckius et al. [33] (CBMC), which includes single- cell protein measurements 
in addition to mRNA provides an alternative way for using computationally- derived 
annotations as a gold standard. Here, we evaluate the extent to which the similarity between 
cells in the mRNA latent space resembles their similarity at the protein level (Online 
Methods).
Overall in these tests, we find that scVI is capable of grouping together cells that are from 
the same annotated sub-population or that express similar proteins and that it compares 
favorably to other methods that aim to infer a biologically meaningful latent space (namely, 
ZIFA [9], ZINB-WaVE [10], DCA [20] and factor analysis; Supplementary Figure 9). 
Notably, we also included in this test a simpler version of scVI that does not explicitly 
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models the library size. We observed that this simpler variant does not perform as well as the 
standard scVI, thus supporting our modeling choice.
Next, we benchmark scVI with SIMLR [11], a method that couples clustering with learning 
a cell-cell similarity matrix and a respective low dimensional (latent) representation. We 
observed that SIMLR provides a tighter representation of the computationally annotated 
subpopulations and that it outperforms scVI in this test. This result is expected since SIMLR 
explicitly aims to produce a tight representation of the data in a target number of clusters. 
However, as a consequence, SIMLR may not capture structural properties of the cell-cell 
similarity map that are of higher resolution. Indeed, in the protein vs. mRNA metric 
similarity test, scVI and DCA are the best performing methods, albeit by a small margin 
(Supplementary Figure 9c). Another example is the possibility of a hierarchical structure 
among cell subsets, such as the one reported for cortical cells by Zeisel and colleagues [29] 
(CORTEX). In this case, we find that overall scVI captures this hierarchy more accurately, 
whereby cells from related sub-populations tend to be closer to each other in its latent space 
(Supplementary Figure 9efg). An additional important case occurs when the variation 
between cells has a continuous, rather than discrete, form. An example for this case was 
studied by Tusi and colleagues who profiled a set of hematopoietic cells, spanning various 
stages of differentiation [32] (HEMATO). Here we find that SIMLR identifies several 
discrete clusters, and does not reflect the continuous nature of this system as well as scVI or 
PCA (Figure 2, Supplementary Figure 10). Finally, there may be the case of lack of 
structure, where the data is almost entirely dominated by noise. To explore this scenario, we 
generated a noise dataset, sampled at random from a vector of zero-inflated negative 
binomial distributions. In this case, SIMLR erroneously reports eleven distinct clusters, 
which are not perceived by other methods (Supplementary Figure 11). Altogether, these 
results suggest that the latent space of scVI is flexible and describes the data well, either as a 
hierarchy of discrete clusters, as a continuum between cell state, or as structureless noise and 
is therefore better suited than SIMLR in scenarios where the data does not necessarily fit 
with a simple structure of discrete cell states.
Accounting for technical variability
scVI provides a parametric distribution designed to decouple the biological signal from the 
effects of sample- level categorial nuisance factors (e.g., representing batch annotations) and 
variation in sequencing depth. To evaluate the capacity of scVI to correct batch effects, we 
used a dataset of mouse retinal bipolar neurons that consists of two batches [31] (RETINA). 
We defined an entropy measure to evaluate the mixing of cells from different batches in any 
local neighborhood of the latent space (abstracted using k-nearest neighbor graph; see 
Online Methods). We compare our method to ComBat [34] - a standard pipeline of batch 
correction relying on linear models and empirical Bayes shrinkage, and a recent method 
based on matching mutual nearest neighbors [35] (Online Methods).
Our results (Figure 2, Supplementary Figures 9d and 12) demonstrate that in this dataset 
scVI aligns the batches significantly better than ComBat and MNNs, while still maintaining 
a tight representation of pre-annotated subpopulations. Considering algorithms that do not 
account for batch effects in their models we find, as expected, that the resulting mixing of 
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the batches is poor. Specifically, while SIMLR and DCA are capable of clustering the cells 
well within each batch, the respective clusters from each batch remain largely separated. 
Similar results were obtained when applying a simplified version of scVI with no batch 
variable, thus supporting our modeling choice.
Turning to confounding due to variation in sequencing depth, we find as expected, that in 
relatively homogenous populations (taking sub-populations of cortical cells [28], BRAIN-
SMALL or PBMC [30]) the library size factor inferred by scVI (ℓn) strongly correlates with 
the observed depth per cell (Supplementary Figure 13a). A related technical issue that can 
distort the simmilarity between cells in these sub-populations is the lack of sensitivity, due to 
limitations in mRNA capture efficiency and to a leser extent sequencing depth, resulting in 
an exacerbated amount of zero entries. Interestingly, we find that most of the zero entires in 
the data can be explained by the negative binomial component (Supplementary Figure 14ab) 
rather than the “inflation” of unexplained zeros added to it with a Bernoulli distribution. 
Consistently, we find that the occurence of zeros entries in is largely consistent with a 
random process of sampling genes from each cell in manner proportional to their expected 
frequency (as inferred in the the matrix ρ of our model, which is proportional to the negative 
binomial mean) and with no additional bias (Supplementary Figure 13b and Supplementary 
Note 2). Indeed, we show that the zero probability from the negative binomial distribution 
correlates more with cell-specific quality factors that are related to library size (e.g., number 
of reads per UMI) while the zero probabilities from the Bernouilli correlates more with 
quality factors indicative of alignment errors (Supplementary Figure 13cd and 14cd) , 
possibly indicative of contamination or mRNA degradation. Taken together, these results 
corroborate the idea that most zeros, at least in the datasets explored here, can be explained 
by low (or zero) “biological” abundance of the respective transcript, exacerbated by limited 
sampling.
Differential expression
With its probabilistic representation of the data, scVI provides a natural way of performing 
various types of hypotheses testing, while intrinsically controlling for nuisance factors. In 
the case of differential expression between two sets of cells, we can use the model to 
approximate the posterior probability of the alternative hypotheses (genes are different) and 
that of the null hypotheses by repeated sampling from our variational distribution, thus 
obtaining a low variance estimate of their ratio (i.e., Bayes factor [36, 37]; see Online 
Methods).
To evaluate scVI against other methods [13, 17, 20, 38] for differential expression, we used a 
dataset of 12,039 PBMCs from a healthy human donor [30] (PBMC) and looked for 
differentially expressed genes in two settings: comparing the clusters of B cells vs. dendritic 
cells, and similarly for the CD4+ vs. CD8+ T cell clusters. As ground truth, we used 
published bulk- level comparative analysis of similar cell subsets [39, 40]. For evaluation, 
we first defined genes as true positives if their BH-adjusted p-values in the bulk data was 
under 0.05 and then calculated the area under the ROC curve (AUROC) based on the Bayes 
factor (for scVI) or BH-corrected p-value (for the benchmark methods). Since defining true 
positives requires a somewhat arbitrary threshold, we also used a second score that evaluates 
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the reproducibility of gene ranking (bulk reference vs. single cell; considering all genes), 
using the irreproducible discovery rate (IDR) [41]. Considering the AUROC metric, scVI is 
the best performing method in the T cell comparison, while edgeR outperforms scVI by a 
smaller margin in the B vs. dendritic cell comparison. Considering the proportion of genes 
with reproducible rank as fitted by IDR, scVI is the best performing method in both 
comparisons (Figure 3, Supplementary Figure 15a-e). Interestingly, we see that the hybrid 
method of DCA followed by DESeq2 constitutes a solid improvement over a direct 
application of DESeq2, which was designed with bulk data in mind, thus supporting the 
need of using models adapted for single cell data. Furthermore, a simpler variant of scVI 
that does not include the library size factor shows extremely poor performance on the B vs. 
dendritic cell comparison, being the only model that does not explicitly handle 
normalization. This is evidence of the usefulness of explicitly including library size 
normalization in the scVI model.
Discussion
scVI was designed to address an important need in the rapidly evolving field of single cell 
transcriptomics – namely, accounting for measurement uncertainty and bias in tertiary 
analysis tasks through a common, scalable statistical model. As such, it provides a 
computationally efficient and “all-inclusive” tool that couples low-dimensional probabilistic 
representation of gene expression data with downstream analysis capabilities, comparing 
favorably to the state-of-the-art methods in each of a range of tasks, including batch-effect 
correction, imputation, clustering, and differential expression.
scVI takes raw count data as input and includes an effective normalization procedure that is 
integrated into its model. First, it learns a cell-specific scaling factor as a hidden variable, 
with the objective of maximizing the likelihood of the data [8, 10, 22], which is more 
justifiable than a posteriori correction of the observed counts [5]. Second, scVI explicitly 
accounts for batch annotations, via a mild assumption of conditional independence. We 
demonstrated that both of these components are essential for the method’s performance. 
Additional discussion, explaining these and other modeling choices is provided in the Online 
Methods section.
The deep learning architecture used in scVI is built on several canonical building blocks 
such as non-linearities, regularization and mean-field approximation to the posterior [25] 
(Online Methods). Exploring other, possibly better, architectures [42] and procedures for 
parameter and hyper-parameter tuning [43] may in some instances provide a better model fit 
and more suitable approximate inference. Notably, since our procedure has a random 
component, and since it optimizes a non-convex objective function, it may give alternative 
results with different initializations. To address this, we demonstrate the stability of scVI in 
terms of its objective function, as well as imputation and clustering (Supplementary Figure 
1). Another related issue is that, if there are few observations (cells) for each gene, the prior 
and the inductive bias of the neural network may keep us from fitting the data closely. 
Indeed, in cases where the number of cells is smaller than the number of genes, some 
procedure to pre-filter the genes may be warranted. A complementary approach would make 
use of techniques such as Bayesian shrinkage [17] or regularization and second order 
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optimization [10]. We do however show that for a range of datasets of varying sizes, scVI is 
able to fit the data well and capture relevant biological diversity between cells.
Looking ahead, scVI provides a general probabilistic representation of gene expression in 
single cells and can therefore enable other forms of scRNA-seq analysis that were not 
explored in this manuscript, such as lineage inference [1] or cell-state annotation [7, 44]. 
Furthermore, since it only requires the latent space and the specification of the model (which 
both have a low memory footprint) to generate any data point (cell × gene) of interest, scVI 
can be used as an effective baseline for scalable and interactive visualization tools [45, 46, 
47]. Finally, scVI can be extended to merge multiple datasets from a given tissue while 
integrating prior biological annotations of cell types. We therefore expect this work to be of 
immediate interest, especially in cases where dataset harmonization has to be done in a 
manner that is scalable and conducive to various forms of downstream analysis [14].
Online Methods
The scVI probabilistic model
First, we present in more detail the generative process for scVI. Altogether, each expression 
value xng is drawn independently through the following process:
zn ∼ Normal 0, I
ℓn ∼ LogNormal ℓμ, ℓσ
2
ρn = f w zn, sn
wng ∼ Gamma ρn
g, θ
yng ∼ Poisson ℓnwng
hng ∼ Bernoulli f h
g zn, sn
xng =
yng if hng = 0
0 otherwise .
A standard multivariate normal prior for z is commonly used in variational autoencoders 
since it can be reparametrized in a differentiable way into any arbitrary multivariate 
Gaussian random variable [25], which turns out to be extremely convenient in the inference 
process.
B denotes the number of batches and ℓμ, ℓσ ∈ ℝ+
B
 parameterize the prior for the scaling 
factor (on a log scale). ℓμ,ℓσ are set to be the empirical mean and variance of the log-library 
size per each batch. Let us note that the random variable ℓn is not the log-library size (scaling 
the sampled observation) itself but a scaling factor that is expected to correlate strongly with 
log-library size (hence the choice of the parameters). The parameter θ ∈ ℝ+G denotes a gene-
specific inverse dispersion, estimated via variational Bayesian inference.
fw and fh are neural networks that map the latent space and batch annotation back to the full 
dimension of all genes: ℝd × {0,1}B → ℝG. We use superscript annotation (e.g., fwg zn, sn ) 
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to refer to a single entry that corresponds to a specific gene g. Neural network fw is 
constrained during the inference to encode the mean proportion of transcripts expressed 
across all genes by using a softmax activation at the last layer. Namely, for each cell n the 
sum of fw
g zn, sn  values over all genes g is one. Neural network fh encodes whether a 
particular entry has been dropped out due to technical effects [9, 10]. These intermediate 
vectors can therefore be interpreted as expected frequencies. Importantly, let us note that 
neural networks allows us to go beyond the generalized linear model framework and provide 
a more flexible model of gene expression. All neural networks use dropout regularization 
and batch normalization. Each network has 1, 2, or 3 fully connected-layers, with 128 or 256 
nodes each. The activation functions between two hidden layers are all ReLU. We use a 
standard link function to parametrize the distribution parameters (exponential, logarithmic or 
softmax). Weights for some layers are shared between fw and fh.
Fast inference via stochastic optimization
The posterior distribution combines the prior knowledge with information acquired from the 
data matrix X. We cannot directly apply Bayes rule to determine the posterior because the 
denominator (the marginal distribution) p(xn|sn) is intractable. Making inference over the 
whole graphical model is not needed. We can integrate out the latent variables wng,hng and 
yng since p(xng|zn,ℓn,sn) has a closed-form density. Notably, the distribution p(xng|zn,sn,ℓn) is 
zero-inflated negative binomial (ZINB) [16] with mean ℓnρng, gene-specific dispersion θg 
and zero-inflation probability f h
g(zn, sn) (see Supplementary Note 3). We discuss numerical 
stability and parametrization of the ZINB distribution in Supplementary Note 4. Having 
simplified our model, we use variational inference [26] to approximate the posterior p(zn,ℓn|
xn,sn). Our variational distribution q(zn,ℓn|xn,sn) is mean-field:
q zn, ℓn xn, sn = q zn xn, sn q ℓn xn, sn
The variational distribution q(zn|xn,sn) is chosen to be Gaussian with a diagonal covariance 
matrix, mean and covariance given by an encoder network applied to (xn,sn), as in [25]. The 
variational distribution q(ℓn|xn,sn) is chosen to be log-normal with the scalar mean and 
variance also given by an encoder network applied to (xn,sn). The variational lower bound is
log p x s ≥ 𝔼q z, l x, s log p x z, l, s
− DKL q z x, s ∥ p z
− DKL q l x, s ∥ p l
(2)
In this objective function, the dispersion parameters θg for each gene are treated as global 
variables to optimize in a Variational Bayesian inference fashion.
To optimize the lower bound, we use the analytic expression for p(x|z,l,s) and use analytic 
expressions for the Kullback-Leibler divergences. We use the reparametrization trick to 
compute low-variance Monte-Carlo estimates of the expectations’ gradients. Analytic 
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closed-form for the Kullback-Leibler divergence and the reparametrization trick are only 
possible on certain distributions which multivariate Gaussians are a part of [25]. The 
reparametrization trick is a specific sampling scheme from the variational distribution which 
makes our objective function stochastic. Remarkably, this sampling step coupled with neural 
networks approximation to the posterior is what makes possible to go beyond restrictive 
“conditional conjugacy” properties often needed to perform sampling or variational 
inference. This allows us to efficiently perform inference with arbitrary models, including 
those with conditional distributions specified by neural networks [25].
A second level of stochasticity comes from sub-sampling from the training set (possible 
since the cells are identically independently distributed when conditioned on the latent 
variables). We then have an online optimization procedure that can handle massive datasets 
— used by scVI as well as other methods that exploit neural networks [18, 19, 20, 21]. At 
each iteration, we focus only on a small subset of the data randomly sampled (M = 128 data 
points) and do not need to go through the entire dataset. Therefore, there is no need to store 
the entire dataset in memory. Because the number of genes is in practice limited to a few 
tens of thousands, these mini-batches of cells fit easily into a GPU. Now, our objective 
function is continuous and end-to-end differentiable, which allows us to use automatic 
differentiation operators.
Throughout the paper, we use Adam (a first order stochastic optimizer) with ε = 0.01. As 
indicated in [27], we use deterministic warmup and batch normalization during learning to 
learn an expressive model. A complete list of hyperparameters is provided in Supplementary 
Table2. The hyperparameters were chosen using a small grid search that maximized held-out 
log likelihood—a common practice for training deep generative models. One of the strengths 
of scVI is that we have only three dataset-specific hyperparameters to set (learning rate, 
number of layers, and layer width). We optimize the objective function until convergence –
usually between 120 and 250 epochs, where each epoch is a complete pass through the 
dataset (let us note that bigger datasets require fewer epochs). For the larger subset of the 
BRAIN-LARGE dataset, we also ran with the early stopping criterion: the algorithm stops 
after 12 consecutive epochs with no improvement on the validation loss.
Since the encoder network q(z|x,s) might still produce output correlated with the bath s, one 
could use in principle a Maximum Mean Discrepancy (MMD) based penalty as in [24] to 
correct the variational distribution. For this paper, however, we did not explicitly enforce the 
MMD penalty and simply retained the conditional independence property, which has shown 
to be sufficiently efficient. This may be useful on other datasets though it explicitly assumes 
the exact same biological signal is present in the datasets.
Bayesian differential expression
For each gene g and pair of cells (za,zb) with observed gene expression (xa,xb) and batch ID 
(sa,sb), we can formulate two mutually exclusive hypotheses:
ℋ1
g: = 𝔼s f w
g za, s > 𝔼s f w
g zb, s vsℋ2
g: = 𝔼s f w
g za, s ≤ 𝔼s f w
g zb, s
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where the expectation 𝔼s is taken with the empirical frequencies. Notably, we propose a 
hypothesis testing that do not to calibrate the data to one batch but will find genes that are 
consistently differentially expressed. Evaluating which hypothesis is more probable amounts 
to evaluating a Bayes factor [37] (Bayesian generalization of the p-value). Its sign indicates 
which of ℋ1
g
 and ℋ2
g
 is more likely. Its magnitude is a significance level and throughout the 
paper, we consider a Bayes factor as strong evidence in favor of a hypothesis if |K| > 3 [36] 
(equivalent to an odds ratio of exp(3) ≈ 20).
K = loge
p ℋ1
g xa, xb
p ℋ2
g xa, xb
where the posterior of these models can be approximated via the variational distribution
p(ℋ1
g | xa, xb) ≈ ∑s∬za, zbp( f w
g (zx, s) ≤ f w
g (zx, s))p(s)dq(za | xa)dq(zb | xb)
where p(s) designated the relative abundance of cells in batch s and all of the measures are 
low-dimensional, so we can use naive Monte Carlo to compute these integrals. We can then 
use a Bayes factor for the test.
Since we assume that the cells are i.i.d., we can average the Bayes factors across a large set 
of randomly sampled cell pairs, one from each subpopulation. The average factor will 
provide an estimate of whether cells from one subpopulation tend to express g at a higher 
frequency.
We demonstrate the robustness of our method by repeating the entire evaluation process and 
comparing the results (Figure 3ab). We also ensure that our Bayes factor are well calibrated 
by running the differential expression analysis across cells from the same cluster and making 
sure no genes reach the significance threshold (Supplementary Figure 15f).
Modeling choices
In this section, we consider the extent to which each of a sequence of modeling choices in 
the design of scVI contributes to its performance. As a baseline approach, consider 
normalizing single-cell RNA sequencing data as in previous literature [9] and reducing the 
dimensionality of the data using a variational autoencoder with a Gaussian prior and a 
Gaussian conditional probability.
One way in which a model can be enhanced is by changing the Gaussian conditional 
probability to one of the many available count distributions, such as zero-inflated negative 
binomial (ZINB), negative binomial (NB), Poisson or others. Recent work by Eraslan and 
colleagues using simulated data shows that when the dropout effect drives the signal-to-
noise ratio to a less favorable regime, a denoising autoencoder with mean squared error (i.e., 
Gaussian conditional likelihood) cannot recover cell-types from expression data while an 
autoencoder with ZINB conditional likelihood can [20]. This results points to the importance 
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of at least modeling the sparsity of the data and is consistent with previous contributions [9, 
10].
The next question is which count distribution to use. In scVI we have chosen to use the zero-
inflated negative binomial, a choice motivated by previous literature (e.g., [10]). First, the 
choice of negative binomial is common in RNA-sequencing data, as it is over dispersed [17]. 
Furthermore, under some assumption this distribution captures the steady state form of the 
canonical two-state promoter activation model [16]. Finally, recent work by Grønbech and 
colleagues [21] proposes an analysis based on Bayesian model selection (held-out log-
likelihood as in this manuscript). In that analysis, the NB and ZINB distribution stand out 
with similarly high scores. We demonstrate that the addition of a zero-inflation (Bernoulli) 
component is important for explaining a subset of the zero values in the data (Supplementary 
Figure 14) and that it captures important aspects of technical variability which are not 
captured by the NB component (Supplementary Figure 13).
To enhance the model further, we added terms to account for library-size as a nuisance 
factor, which can be considered as a Bayesian approach to normalization as in [8, 22]. We 
showed how this contributes to our model by increasing clustering scores and differential 
expression analysis accuracy on the PBMC dataset.
As a further enhancement, we designed the generative model to explain data from different 
experimental batches. This is not a trivial task as there may exist a significant covariate shift 
between the observed transcript measurements. We showed how this modification to our 
model is crucial when dealing with batch effects in subsection on the RETINA dataset.
Datasets and preprocessing
Below we describe all of the datasets and the preprocessing steps used in the paper. We 
focus on relatively large datasets (3k cells and more) with unique molecular identifiers 
(UMIs), thus providing enough information during training and avoiding the problem of 
over- counting due to amplification. A star after the dataset name indicates we used it as an 
auxiliary dataset; these datasets were not used for general benchmarking, but rather to 
support specific points presented in the paper. The only case where we subsampled the data 
multiple times was the BRAIN-LARGE dataset. However, we simply used one instance of it 
to report all possible scores (further details in Supplementary Table 2).
CORTEX—The Mouse Cortex Cells dataset from [29] contains 3005 mouse cortex cells 
and gold-standard labels for seven distinct cell types. Each cell type corresponds to a cluster 
to recover (see Supplementary Table 4). We retain the top 558 genes ordered by variance as 
in [8].
PBMC—We considered scRNA-seq data from two batches of peripheral blood mononuclear 
cells (PBMCs) from a healthy donor (4K PBMCs and 8K PBMCs) [30]. We derived quality 
control metrics using the cellrangerRkit R package (v. 1.1.0). Quality metrics were extracted 
from CellRanger throughout the molecule-specific information file. After filtering as in [23], 
we extract 12,039 cells with 10,310 sampled genes and generate biologically meaningful 
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clusters with the software Seurat (see Supplementary Table 5). We then filter genes that we 
could not match with the bulk data used for differential expression to be left with g = 3346.
BRAIN LARGE—This dataset contains 1.3 million brain cells from 10x Genomics [28]. 
We randomly shuffle the data to get a 1M subset of cells and order genes by variance to 
retain first 10,000 and then 720 sampled variable genes. This dataset is then sampled 
multiple times in cells for the runtime and goodness-of-fit analysis. We report imputation 
scores on the 10k cells and 720 gene samples only.
RETINA—After their original pipeline for filtering, the dataset of bipolar cells from [31] 
contains 27,499 cells and 13,166 genes from two batches. We use the cluster annotation 
from 15 cell-types from the author. We also extract their normalized data with Combat and 
use it for benchmarking.
HEMATO—This dataset with continuous gene expression variations from hematopoeitic 
progenitor cells [32] contains 4,016 cells and 7,397 genes. We removed the library basal-
bm1, which was of poor quality, based on authors recommendation. We use their population 
balance analysis result as a potential function for differentiation.
CBMC*—This dataset includes 8,617 cord blood mononuclear cells [33] profiled using 10x 
along with 13 well-characterized mononuclear antibodies for each cell. We kept the top 600 
genes by variance.
BRAIN SMALL*—This dataset, which consists of 9,128 mouse brain cells profiled using 
10x [28], is used as a complement to PBMC for our study of zero abundance and quality 
control metric correlation with our generative posterior parameters. We derived quality 
control metrics using the cellrangerRkit R package (v. 1.1.0). Quality metrics were extracted 
from CellRanger throughout the molecule-specific information file. We kept the top 3000 
genes by variance. We used the clusters provided by cellRanger for the correlation analysis 
of zero probabilities.
Statistics
Differential expression for bulk datasets—Specifically, we assembled a set of genes 
that are differentially expressed between human B cells and dendritic cells (microarrays, n = 
10 in each group [39], GSE29618) and between CD4+ and CD8+ T cells (microarrays, n = 
12 in each group [40], GSE8835). For GSE29618, we first loaded bulk human expression 
array data using the GEOquery package, selecting all B cell and myeloid dendritic cell 
(mDC) samples from the baseline (“Day0”) timepoint. We retained all expression features 
described by exactly one Gene Symbol, and regressed the expression of these expression 
measures on cell type covariate (B cell vs mDC) using lmFit linear modeling in limma. p-
values were derived from empirical Bayes moderated t-tests for difference between the two 
cell types, using eBayes in limma. We conducted a identical study on GSE8835 for the 
CD4+ and CD8+ T cells comparison. These p-values are then corrected using the standard 
Benjamini & Hochberg procedure.
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Differential expression for scRNA-seq datasets—We used the packages as detailed 
in the Methods section. These p-values are then corrected using the standard Benjamini & 
Hochberg procedure.
Capturing technical variability—We compute the average probability of zero from the 
negative binomial distribution and from the Bernouilli across all gene for a particular cell. 
We test for a correlation between these cell-specific zero probabilities and cell-specific 
quality control metrics using a Pearson-correlation test.
Evaluation
We describe below how we compute the metrics used in the manuscript. For a further details 
of the algorithms used for benchmarking in this study, refer to the Supplementary Note 5.
Log-likelihood on held-out data—We provide a multi-variate metric of goodness of fit 
on the data in Supplementary Note 6.
Corrupting the datasets for imputation benchmarking—In this paper we use two 
different approaches to measure the robustness of algorithms to noise in the data:
• Uniform zero introduction: We randomly select ten percent of the non-zero 
entries and multiply the entry n with a Ber(0.9) random variable.
• Binomial data corruption: We randomly select 10% of the matrix and replace an 
entry n with a Bin(n,0.2) random variable.
Accuracy of imputing missing data—As imputation tantamount to replace missing 
data by its mean conditioned on being observed, we use the median 𝕃1 distance between the 
original dataset and the imputed values for corrupted entries only. We now define what the 
imputed values are. For MAGIC, we use the output of their algorithm. For BISCUIT, we use 
the imputed counts. For ZIFA, we use the mean of the generative distribution conditioned on 
the non-zero event (mean of the factor analysis part) that we project back into count space. 
For scVI and ZINB-WaVE, we use the mean of the Negative Binomial distribution.
Silhouette width—The silhouette width requires either a similarity matrix or a latent 
space. We can define a silhouette score for each sample i with
s(i) = b i − a imax a i , b i
where a(i) is the average distance of i to all data points in the same cluster ci and b(i) is the 
lowest average distance of i to all data points in the same cluster c among all clusters c. 
Clusters can be replaced with batches if we are estimating the silhouette width for assessing 
batch effects [23].
Clustering metrics—The following metrics require a clustering and not simply a 
similarity matrix. For these, we will use a k-means clustering on the given latent space of 
dimension 10 with T = 200 random initializations to achieve a stable score.
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Adjusted Rand Index—This index requires a clustering. Most
ARI =
∑i j
ni j
2
− [∑i
ai
2
∑ j
b j
2
]/ n2
1
2[∑i
ai
2
+ ∑ j
b j
2
] − [∑i
ai
2
∑ j
b j
2
]/ n2
where nij,ai,bj are values from the contingency table.
Normalized Mutual Information—
NMI = I P;Tℍ P ℍ T
where P,T designates empirical categorical distributions for the predicted and real clustering. 
I is the mutual entropy and ℍ is the Shannon entropy.
Entropy of batch mixing—Fix a similarity matrix for the cells and take U to be a 
uniform random variable on the population of cells. Take BU the empirical frequencies for 
the 50 nearest neighbors of cell U being a in batch b. Report the entropy of this categorical 
variable and average over T = 100 values of U.
Protein abundance / mRNA expression—Take the similarity matrix for the 
normalized protein abundance (centered log-ratio transformation, see [33]). Compute a 100 
nearest neighbors graph. Fix a similarity matrix for the cells and compute a 100 nearest 
neighbors graph. Report the Spearman correlation of the flattened matrices and the fold 
enrichment.
Let A be the set of edges in the protein NN graph, B the set of edges in the cell NN graph 
and C the entire set of possible edges. The fold enrichment is defined as
|A ∩ B | × |C|
|A | |B|
Differential expression metrics—We used 100 cells from each cluster. In scVI, we 
draw 200 samples from the variational posterior; subsampling ensures that our results are 
stable.
Area under the curve—We assign each gene with a label of DE or non-DE based on 
their p-values from the reference data (genes with a BH corrected p-values under 0.05 are 
positive and the rest are negative); then these labels to compute AUROC
Irreproducible Discovery Rate—The IDR is computed using the corresponding R 
package. We adjust the prior for the mixture weight to be the fraction of genes detected in 
the micro-array data.
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Software Availability
An open-source software implementation of scVI is available on Github (https://github.com/
YosefLab/scVI). All code for reproducing results and figures in this manuscript is deposited 
at https://zenodo.org/badge/latestdoi/125294792 and included as Supplementary Software.
Reporting Summary
Further information on experimental design is available in the Nature Research Reporting 
Summary.
Data availability
All of the datasets analyzed in this manuscript are public and referenced at https://
github.com/romain-lopez/scVI-reproducibility.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1: 
Overview of scVI. Given a gene-expression matrix with batch annotations as input, scVI 
learns a non-linear embedding of the cells that can be used for multiple analysis tasks. (a) 
The computational trees (neural networks) used to compute the embedding as well as the 
distribution of gene expression. (b) Comparison of running times (y-axis) on the BRAIN-
LARGE data with a limited set of 720 genes, and with increasing input sizes (x-axis; cells in 
each input set are sampled randomly from the complete dataset). All the algorithms were 
tested on a machine with one eight-core Intel i7–6820HQ CPU addressing 32 GB RAM, and 
one NVIDIA Tesla K80 (GK210GL) GPU addressing 24 GB RAM. scVI is compared 
against existing methods for dimensionality reduction in the scRNA-seq literature. As a 
control, we also add basic matrix factorization with factor analysis (FA). For the one-
million-cell dataset only, we report the result of scVI with and without early stopping (ES).
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Figure 2: 
Biological signal retained by the latent space of scVI. scVI is applied to three datasets (from 
right to left: CORTEX n = 3,005 cells, HEMATO n = 4,016 cells and RETINA n = 27,499 
cells). For CORTEX and HEMATO, we compare scVI with SIMLR and show a distance 
matrix in the latent space, as well as a two-dimensional embedding of the cells. Distance 
matrices: the scales are in relative units from low to high similarity (over the range of values 
in the entire matrix). Cells in the matrices are grouped by their pre-annotated labels, 
provided by the original studies (for the CORTEX dataset, cell subsets were ordered using 
hierarchical clustering as in the original study). Embedding plots: each point represents a 
cell and the layout is determined either by tSNE for CORTEX or by a 5-nearest neighbors 
graph visualized using a Fruchterman-Reingold force-directed algorithm for HEMATO; see 
Supplementary Figure 10d for the original embedding for SIMLR. Color scheme in the 
embeddings is the same as in the distance matrices. For the RETINA dataset, we compare 
scVI with MNNs followed by PCA. Embedding plots were generated by applying tSNE on 
the respective latent space. On the left, the cells are colored by batch. On the right, cells are 
colored by the annotation of subpopulations, provided in the original study [31].
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Figure 3: 
Benchmark of differential expression analysis using the PBMC dataset (n = 12,039 cells), 
based on consistency with published bulk data. (a, b) Evaluation of consistency with the 
irreproducible discovery rate (IDR) [41] framework (blue) and using AUROC (green) is 
shown for comparisons of B cells vs Dendritic cells (a) and CD4 vs CD8 T cells (b). Error 
bars are obtained by sub-sampling a hundred cell from each clusters n = 20 times to show 
robustness. Box plots indicate the median (center lines), interquantile range (hinges) and 5–
95th percentiles (whiskers). (c,d,e,f): correlation of significance levels of differential 
expression of B cells vs Dendritic cells, comparing bulk data and single cell. Points are 
individual genes (n = 3,346). Bayes factors or BH-corrected p-values on scRNA-seq data are 
presented on the x-axis; microarray-based BH-corrected p-values are depicted on the y-axis. 
Horizontal bars denote significance threshold of 0.05 for corrected p-values. Vertical bars 
denote significance threshold for the Bayes factor of scVI (c) or 0.05 for corrected p-values 
for DESeq2 (d), edgeR (e), and MAST (f). We also report the median mixture weight for 
reproducibility p (higher is better).
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